SE

Sandrine Egron

Investment Director at 50 Partners

France

Overview 

Sandrine Egron is an Entrepreneur and Investment Director at 50Partners Health in France, with a background in management, medical devices, and business development. She has co-founded and led successful ventures like InnYTe and Vivosim, and currently focuses on investing in digital health and health IT startups at various stages. Sandrine's career highlights include co-founding successful companies like InnYTe and Vivosim, and her current role as Investment Director at 50Partners Health, where she specializes in investing in digital health and health IT startups.

Work Experience 

I

Investir&+

  • Investment Director

    2025 - Current

5P

50 Partners

  • Investment Director - 50 Partners Health

    2022

    Portfolio companies: Pixacare, Surge, Jeen, Ensweet, Gutycare (Exit: acquired by Resilience), En Carta Diagnostics, Biohive, Glaaster, Medicud, Maisons Soma, Wyes. - Co-built 50 Partners Health, the first healthcare-focused accelerator within 50 Partners. - Launched the FPCI fund 50 Partners Capital Health. - Strategic support for portfolio startups.

EC

En Carta Diagnostics

  • Board Member

    2024

E-

Ensweet - telerehabilitation solutions

  • Board Member

    2022

S

Susu

  • Chief Operating Officer

    2022 - 2022

    Conducted on-ground fieldwork with the local team in Abidjan to refine healthcare assistance offerings and pricing strategy, while preparing partnerships with medical centers.

I

InnYTe

  • Co-founder and CEO

    2018 - 2021

    - Built a team of exceptional co-founders (Pr. Dinh Xuan Anh Tuan and Philippe Nguyen), medical professionals, and developers. - Developed a DTx platform for chronic respiratory disease patients, successfully tested with users. - Designed a clinical trial with Vietnam’s top 4 respiratory departments (suspended due to COVID-19). - Secured significant public exposure through media (press and national TV).

FH

French Healthcare Vietnam (FHV: Club Santé Vietnam)

  • Leader Innovative Health Group

    2019 - 2020

    Appointed to guide the Innovative Health group of the ‘Club Santé Vietnam’: a lobbyist group which gathered 30 French healthcare companies active in Vietnam. (Among them: Sanofi, Servier, Urgo)

  • Life Sciences Consultant

    2017 - 2018

    Provided due diligence services for investment and consulting firms in the healthcare sector. (E.g. MD Start)

V

Vivosim

  • Co-Founder

    2016 - 2017

    Vivosim AI is based on proprietary algorithms which can be used to improve drug dosing strategies along cancer treatment cycles, for higher efficacy and safety in each patient. - Secured a pilot project in hemato-oncology with Innate Pharma (a listed biotech company specialized in immunotherapy) - Managed the pilot delivery, exceeding the expectations of Innate Pharma’s CMO and CTO

RA

RWTH Aachen University

  • R&D Project Manager in Medical Device Development

    2014 - 2016

    At the Helmholtz Institute, Cardiovascular Engineering department (CVE): - Managed preclinical medical device development projects (heart valve prosthesis, embolic protection device). - Published seven articles and gave talks (in France, Germany, Poland) presenting independent research on the risks associated with cardiovascular interventions. -> Earned my PhD (Dr. rer. medic.) for this work

Education 

Articles About Sandrine

Relevant Websites